PTK2 and pulmonary fibrosis: In line with this hypothesis, different protein kinase inhibitors have successfully reduced collagen deposition and myofibroblast population (two critical markers of organ fibrosis) concomitantly with a reduction in the phosphorylation/activation of FAK and Akt in the bleomycin model of pulmonary fibrosis [39,63,65].